Skip to main content
All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for NOVOCURE INC. · Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Hampshire · House · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
 Lobbying activity 2
Medicare/Medicaid

Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.

Pharmacy

Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem